Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Molecular Diagnostics

Image: Three-dimensional crystal structure of Anti-müllerian hormone bound to its receptor, AMHR2 (Photo courtesy of Wikimedia Commons)

Circulating Levels of Anti-Müllerian Hormone Can Identify Premenopausal Women Prior to Significant Bone Density Loss

The level of anti-Müllerian hormone (AMH) in the blood has been linked to menopause-related bone loss and may be used to identify women who are experiencing, or about to experience, bone loss related to their transition into menopause. More...
07 Apr 2022
Image: The GNRI diagnostic system is easy to use, rapid and sensitive (Photo courtesy of Unsplash)

POC Sepsis Diagnostic Platform to Speed up Clinical and Treatment Decision Making

Great North Research & Innovation (GNRI, Newcastle Upon Tyne, UK) is building a patient focused tool to assist clinicians in determining the causative pathogens in sepsis rapidly and accurately. More...
06 Apr 2022
Image: Voice-activated pipettes use AI to offer workflow benefits (Photo courtesy of INTEGRA Biosciences)

AI-Powered Voice-Activated Pipettes Streamline Processes and Increase Lab Productivity

Voice-activated pipettes are now set to become the future of pipetting. INTEGRA Biosciences (Zizers, Switzerland) has made its first foray into the world of artificial intelligence with the release of voice-activated pipettes that are designed to offer workflow benefits far beyond simplifying pipetting tasks. More...
06 Apr 2022
Image: Li-Fraumeni Syndrome: a) High-grade invasive ductal carcinoma with p53 overexpression; b) mutant pattern in a patient with a germline TP53 missense mutation (Photo courtesy of Brigham and Women’s Hospital)

Liquid Biopsy Enables Early Cancer Detection in Li-Fraumeni Syndrome Patients

Patients with Li-Fraumeni Syndrome (LFS) harbor germline pathogenic variants in the TP53 gene causing predisposition to many cancers from childhood through late adulthood and can accelerate the onset of cancer by more than 30 years. More...
05 Apr 2022
Image: World-first bedside genetic test could prevent babies going deaf (Photo courtesy of The University of Manchester)

World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies

A new bedside machine takes just 25 minutes to identify whether a critically ill baby admitted to intensive care has a gene that could result in permanent hearing loss if they are treated with a common emergency antibiotic. More...
05 Apr 2022
Image: World-first bedside genetic test could prevent babies going deaf (Photo courtesy of The University of Manchester)

World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies

A new bedside machine takes just 25 minutes to identify whether a critically ill baby admitted to intensive care has a gene that could result in permanent hearing loss if they are treated with a common emergency antibiotic. More...
05 Apr 2022
Image: Proteins could one day allow breast cancer screening to be done with a blood test (Photo courtesy of Unsplash)

Blood Test to Detect Protein Biomarkers Identified Using Breast Milk Could Enable Breast Cancer Screening

A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers identified by researchers using breast milk. The newly identified biomarkers are for a specific type of cancer called invasive ductal carcinoma (IDC), one of the most common types of breast cancers, but the approach could be used to identify biomarkers for other types of breast cancer as well. More...
05 Apr 2022
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Silver Member
PCR Plates
Diamond Shell PCR Plates


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.